CIDRAP newsletters options
The Bill & Melinda Gates Foundation, Novo Nordisk Foundation, and Wellcome are collaborating on a $50 million effort to boost discovery of novel antibiotics for gram-negative bacteria.
Frequent interactions between antimicrobial stewardship physicians and pharmacists and use of local antibiotic prescribing guidelines were tied to less antibiotic use at discharge.
Nebraska conducts CWD surveillance in 4 to 7 regions each year, rotating to a different part of the state each season.
USDA testing confirmed detections in cats from California, Montana, and Oregon.
Notably, 20% of nurses surveyed suffered the loss of a family member.
Clinicians should monitor post-COVID cardiovascular symptoms, even in patients without a history of cardiovascular disease, the authors say.
The death total remains at one, the index patient who died in late January.
Both patients, boys ages 2 and 15 years old, are from Hunan province in southern China.
Nasal administration could help to achieve mucosal immunity.
Immunocompromised participants were much more likely to have received at least four doses of COVID-19 vaccine than their otherwise healthy peers (73% vs 30%).
Pearl Diagnostics will receive $1 million to evaluate the potential of a prototype assay for early detection of pneumonia caused by Pseudomonas aeruginosa.
Tests on milk from farms in the county where the worker is from yielded the first detection of the D1.1 genotype in dairy cattle.
A substantial reduction was seen in practices offering weekend hours or advanced-access scheduling.
Contacts of the patient are being closely monitored and offered preventive vaccination.
Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment options.
The rate of gonorrhea cases across Europe rose by 31% in 2023 compared with 2022, and is up 321% since 2014.
The global research agenda includes 33 research priorities for bacterial and fungal infections and 7 for drug-resistant tuberculosis.
The effect of financial incentives on primary and booster vaccinations was nonsignificant.
The rate of antiviral prescriptions was 67% lower in pregnant than in nonpregnant women, including those with 1 or more high-risk underlying conditions.
PAHO is tracking a rise in dengue serogroup 3 activity, which could raise the risk of severe illness as countries approach the peak of the season.
